promising novel agents for hemophilia a/b: gene therapies and extended half-life products
Published 11 months ago • 73 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
1:23
the present and future of hemophilia a treatment
-
1:57
aav gene therapies for hemophilia a and b
-
1:14
promising novel agents in aml: menin inhibitors
-
1:48
the promise of fitusiran for the treatment of patients with hemophilia a and b
-
1:05
promising antibodies being explored in hemophilia & a novel diagnostic tool for patients
-
3:01
novel promising agents and clinical trials in amyloidosis
-
0:51
empowering patients with hemophilia to make choices about gene therapy
-
3:07
aav-based gene therapy in hemophilia a and b: valoctocogene roxaparvovec & etranacogene dezaparvovec
-
1:01
gene therapy as a future treatment for hemophilia
-
0:39
promising therapeutic options emerging in hemophilia
-
1:41
promising novel approaches for inhibitor suppression in hemophilia
-
4:57
a potential novel hemophilia treatment: an in vitro study of eptacog beta and emicizumab
-
3:49
hope-b trial: etranacogene dezaparvovec shows promise in hemophilia b
-
1:34
promising novel agents for relapsed/refractory multiple myeloma
-
2:21
gene therapy for hemophilia b found safe and effective in first phase iii trial
-
1:19
novel combination therapy for cmml: jak inhibitor pacritinib plus azacitidine
-
18:10
gene therapy for hemophilia